Medtronic plc

NYSE:MDT

88.75 (USD) • At close July 1, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025202420232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992199119901989198819871986
Revenue 33,53732,36431,22731,68630,11728,91330,55729,95329,71028,83320,26117,00516,59016,18415,93315,81714,59913,51512,29911,29210,054.69,087.27,665.26,410.85,551.85,014.64,134.12,604.82,438.22,169.11,742.41,390.91,328.21,176.91,021.4836.6741.7653.3502402.8
Cost of Revenue 11,56811,21610,71910,14510,4839,4249,1559,0559,2919,1426,3094,3334,1263,8893,9123,8123,5183,4463,1682,815.32,446.42,252.91,890.31,652.71,113.31,076.3889.7532.8493.3477.9433.6353.1350.5322.4285.2232.4194.4181142.8117.5
Gross Profit 21,96921,14820,50821,54119,63419,48921,40220,89820,41919,69113,95212,67212,46412,29512,02112,00511,08110,0699,1318,476.77,608.26,834.35,774.94,758.14,438.53,938.33,244.42,0721,944.91,691.21,308.81,037.8977.7854.5736.2604.2547.3472.3359.2285.3
Gross Profit Ratio 0.6550.6530.6570.680.6520.6740.70.6980.6870.6830.6890.7450.7510.760.7540.7590.7590.7450.7420.7510.7570.7520.7530.7420.7990.7850.7850.7950.7980.780.7510.7460.7360.7260.7210.7220.7380.7230.7160.708
Reseach & Development Expenses 2,7322,7352,6962,7462,4932,3312,3302,2532,1932,2241,6401,4771,5571,4901,5081,4831,3551,2751,2391,112.9951.3851.5749.4646.3577.6479.7429.2297.2280.2236.7191.4156.300000000
General & Administrative Expenses 0000000000000000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000000000000000
SG&A 10,84910,73610,41510,0479,9569,88210,27310,2389,7119,4696,9045,8475,6985,6235,5335,4155,1524,7074,1533,659.43,213.62,801.42,371.91,962.81,685.21,587.91,280.1757.6763.3695.6574.6470.3613549.1483.3399.8373313.2227.1185.7
Other Expenses 02,5331,5672,5952,0981,8272,5642,3282,2022,0388515304393354594683960000000297.3243.3213.1137.6116.9111.8106.578.669.659.446.539.444.62926.423.3
Operating Expenses 13,58116,00414,67815,63314,73914,26715,13414,55514,10613,7319,3957,8547,6947,8997,2537,7406,9035,9825,3924,772.34,164.93,652.93,121.32,609.12,560.12,310.91,922.41,192.41,160.41,044.1872.5705.2682.6608.5529.8439.2417.6342.2253.5209
Operating Income 5,9555,1445,4855,7524,4844,7916,2686,6515,3305,2913,7663,8134,6394,4834,4604,3713,4643,6513,7393,7053,4443,181.42,653.62,1491,878.41,683.51,360.41,091.7913.8636442.1332.6299.1242.9206.4165129.7131.1105.777.7
Operating Income Ratio 0.1780.1590.1760.1820.1490.1660.2050.2220.1790.1840.1860.2240.280.2770.280.2760.2370.270.3040.3280.3430.350.3460.3350.3380.3360.3290.4190.3750.2930.2540.2390.2250.2060.2020.1970.1750.2010.2110.193
Total Other Income Expenses Net -327-307-121-235-589-736-1,071-965-781-1,025-280-108-388-338-796-427-1,024-766-224-543.7-900-384.5-312.3-624.8-329-68.7-535.3-389.7-27.1235.814.218.4-3.1-10.1-5.120.61315.4
Income Before Tax 5,6284,8375,3645,5173,8954,0555,1975,6754,6024,3363,4863,7054,2514,1453,7233,9692,5942,8853,5153,161.32,543.52,796.92,341.31,524.21,549.41,629822702886.7659442.1346.8313.5242.9196.3159.9150.3131.1108.791.7
Income Before Tax Ratio 0.1680.1490.1720.1740.1290.140.170.1890.1550.150.1720.2180.2560.2560.2340.2510.1780.2130.2860.280.2530.3080.3050.2380.2790.3250.1990.270.3640.3040.2540.2490.2360.2060.1920.1910.2030.2010.2170.228
Income Tax Expense 9361,1331,580456265-7515472,580578798811640784730627870425654713614.6739.6837.6741.5540.2503.4530.5353.6316.8303.5230.6148.1114.4101.981.462.951.252.944.634.924.3
Net Income 4,6623,6763,7585,0393,6064,7894,6313,1044,0283,5382,6753,0653,4673,6173,0963,0992,1692,2312,8022,546.71,803.91,959.31,599.89841,0461,098.5468.4594.6583.2428.3294232.4197.2161.5133.4108.797.486.573.853.4
Net Income Ratio 0.1390.1140.120.1590.120.1660.1520.1040.1360.1230.1320.180.2090.2230.1940.1960.1490.1650.2280.2260.1790.2160.2090.1530.1880.2190.1130.2280.2390.1970.1690.1670.1480.1370.1310.130.1310.1320.1470.133
EPS 3.632.772.833.752.683.573.442.292.922.512.443.063.43.432.872.81.851.972.442.111.491.611.310.810.870.910.40.520.510.450.320.250.210.170.140.120.110.10.090.06
EPS Diluted 3.612.762.823.732.663.543.412.272.892.482.413.023.373.412.862.791.841.952.412.091.481.61.30.80.850.890.390.510.50.450.320.250.210.170.140.120.110.10.090.06
EBITDA 5,9558,2038,6978,7777,5227,8259,3689,4659,0278,5395,4585,6455,5385,3274,9185,1433,5103,7774,3224,172.83,061.93,6243,061.72,478.82,175.71,927.41,579.51,258.21,045.3748542.8411.2364.7305.4252.9204.4174.3159.1132.199.6
EBITDA Ratio 0.1780.2530.2790.2770.250.2710.3070.3160.3040.2960.2690.3320.3340.3290.3090.3250.240.2790.3510.370.3050.3990.3990.3870.3920.3840.3820.4830.4290.3450.3120.2960.2750.2590.2480.2440.2350.2440.2630.247